πŸ‡ΊπŸ‡Έ FDA
Patent

US 6015811

Antitumor Chrysene derivatives

expired A61PA61P35/00

Quick answer

US patent 6015811 (Antitumor Chrysene derivatives) held by The Board of Regents of the University of Texas System expires Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time). Status: expired.

Key facts

Applicant
The Board of Regents of the University of Texas System
Grant date
Tue Jan 18 2000 00:00:00 GMT+0000 (Coordinated Universal Time)
Expiration
Mon Jan 13 2020 00:00:00 GMT+0000 (Coordinated Universal Time)
Claims
32
CPC classes
A61P, A61P35/00